Microport Scientific Corp
HKEX:853

Watchlist Manager
Microport Scientific Corp Logo
Microport Scientific Corp
HKEX:853
Watchlist
Price: 10.79 HKD -1.01% Market Closed
Market Cap: 20.6B HKD

Net Margin
Microport Scientific Corp

-16.1%
Current
-39%
Average
1.8%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-16.1%
=
Net Income
-163.8m
/
Revenue
1B

Net Margin Across Competitors

No Stocks Found

Microport Scientific Corp
Glance View

Market Cap
20B HKD
Industry
Health Care

MicroPort Scientific Corporation, a burgeoning force in the medical devices industry, has carved a niche for itself as an innovative leader headquartered in the bustling city of Shanghai, China. Founded in 1998, the company embarked on its mission to enhance lives by providing cutting-edge medical solutions. Operating in diverse fields such as cardiovascular, orthopedics, endovascular, and neurovascular, MicroPort thrives on its commitment to developing innovative products. The cornerstone of its business model is its robust research and development infrastructure, which fuels a pipeline of new products and drives advancements in medical technology. By leveraging strategic partnerships and acquisitions, MicroPort continually expands its capabilities, tapping into global expertise and elevating its standing in the competitive landscape. The company's revenue model is built upon the sale and distribution of high-performance medical devices across various international markets. Through a vast network of distributors and direct sales teams, MicroPort targets hospitals, clinics, and healthcare providers. Its portfolio includes stents for cardiovascular needs, orthopedic implants, and pacemakers, each designed to address specific therapeutic requirements. The firm's strategic emphasis on innovation, manufacturing prowess, and quality assurance augments its ability to meet rising healthcare demands globally. By focusing on solutions that improve patient outcomes and streamline healthcare delivery, MicroPort not only reinforces its market presence but also captures a significant market share. Thus, through its dual focus on expanding its technological offerings and growing its global footprint, MicroPort sustains its economic engine and continues its trajectory of consistent growth.

Intrinsic Value
10.6 HKD
Overvaluation 2%
Intrinsic Value
Price
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-16.1%
=
Net Income
-163.8m
/
Revenue
1B
What is the Net Margin of Microport Scientific Corp?

Based on Microport Scientific Corp's most recent financial statements, the company has Net Margin of -16.1%.

Back to Top